Li, Z., Xu, G., & Li, X. (2021). A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity. MDPI AG.
Cita Chicago Style (17a ed.)Li, Zhi-Ying, Guang-Sen Xu, y Xun Li. A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity. MDPI AG, 2021.
Cita MLA (8a ed.)Li, Zhi-Ying, et al. A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.